DRIO News 08/27/2014 10:21:14 $DRIO Up we go! Congrats to

New Post Public Reply Private Reply Replies (0) Message Board
Jake13
DRIO News 08/27/2014 10:21:14 $DRIO
Up we go! Congrats to all that loaded at these low levels today! Looks so much better than yesterday! Starting to look like a real trade now!

DRIO
I told you

DRIO Stock Message Board http://investorshangout.com/LabStyle-Innovati...RIO-87707/

072 we going green folks..DRIO
$DRIO Ask is thinning out. BOOM time a-cometh.

imo.
She's coming around the mountain

DRIO
we rising north...0.071
agreed, locked and loaded....Not worth flipping down here... This is a $5.3m valuation currently, this had a $23m value June 30th... Once the smoke settles from the dilution the company and Investors/Traders will see this is undervalued and will start running to .20-.30 !
The current share price is lower than the Share Exchange Agreement (SEA) buyer's average by a couple cents at worst.

DRIO
During the first half and the early third quarter of 2014, LabStyle believes that its roll out execution is on target as he following milestones were achieved:
•Commenced first shipments of the Dario™ Diabetes Management Solution to distributors in Italy, New Zealand, the United Kingdom and the Netherlands, collecting initial positive feedback from the market of people with diabetes.
•Received reimbursement status in England, Wales, Scotland and Northern Ireland for strips and lancets to be utilized together with the Dario™ smart meter (effective September 1, 2014).
•Received national and regional insurance reimbursement approval for the Dario™ Personalized Smart Meter in Italy. LabStyle is actively seeking reimbursement in other strategic territories.
•Received approval from Israel's Ministry of Health to sell the Dario™ smart meter for diabetes in Israel.
•Released the Dario™ Diabetes Management App for Android smartphone users. The mobile application has the same user interface and features as the iOS Dario™ Application and is currently available for download in select soft launch markets. The Android supported Dario smart meter will be released in early September.
•Received a Notice of Allowance from the U.S. Patent and Trademark Office for core patent claims covering the Dario™ personalized smart meter, which works in tandem with the novel and powerful Dario™ software application to form the overall Dario™ Diabetes Management Solution.
•Working with FDA towards potential clearance of the Dario™ smart meter in the U.S. following a 510K filing made in late December 2013.
•Partnered with FatSecret, a leading global nutrition data source, to integrate such data into the Dario™ Diabetes Management Solution.
•Raised $3.8 million in net proceeds from private placement which had its closing on February 2014.
•LabStyle's business strategy and goals assuming adequate funding for the remainder of 2014 and into 2015 include: Expedite production of Dario™ personalized smart meters for both Android and iOS smartphone operating systems, in selected jurisdictions with maximum optimization and efficiency.
•Continue to enhance logistics and shipment process in order to ship and deliver Dario™ personalized smart meters and test strips in a timely and productive manner.
•Expand distributor network with purchase commitments from strategic markets.
•Increase awareness of Dario™ and sales penetration in key target markets.
•Facilitate reimbursement in key target markets.
•Continue to refine and enrich the cutting edge software component of the Dario™ Diabetes Management Solution.
•Obtain 510K FDA clearance for the Dario™ personalized smart meter by early 2015.
•Establish an online sales strategy.
•Utilize the information collected from customer feedback and strategic agile marketing techniques in the long-term roll-out strategy.
•Augment LabStyle's intellectual property portfolio with additional potential patent approvals in the U.S. and globally.

Yes sirrrr and I am locked and loaded AND loading more, I know what's coming. Anyway gotta run a few quick errands I'll be back later.
after 073 we will see a buying pressure. to much upward potential for next days on any news easy 400% potential short term
$DRIO A few nice hits at .07; consolidation in this range, .07 +/-, so far today, imo.
The initial launch of the Dario™ smart meter which has been underway since late March 2014 has met with promising market demand demonstrated in the initial soft launch territories; the United Kingdom, Italy, and New Zealand.

The initial launch feedback includes the following:
•Dario™ has been well received with excellent feedback from users. This has resulted in over 20,000 thousand of Dario app downloads in the six month period only in the soft launch territories, and a higher than average pick up rate thus indicating the feasibility to convert downloads to users in an efficient and productive manner.
•Built a strong supportive community of people with diabetes using Dario™ for their diabetes management needs, primarily in the United Kingdom.
•Surpassed the accepted industry average pickup rate for new users. The current pick up rate of over 68% of these users is due to their very positive experience with Dario™.
•Number of Dario™ smart meter users has passed 2,000 and is growing. Reimbursement codes took longer than expected to be obtained and therefore, the number of users has been constrained and below expectations. Now that reimbursement codes have been secured the user growth rate is expected to accelerate.

spike into the green so save. DRIO perfect setting.
Yep the fundamentals here are rock solid...September's going to be an epic month!!!
DRIO LOOKING GOOD
Things are in the works people ;]

Not gonna say more! Load THA boat :]

$DRIO
Gotta take out these 7's
ABOUT THE DILUTION!!!

- the issuing of shares has concluded per Fridays 8-K making 75m O/S

- The people who got the new issued shares are free to do whatever they want w/ it, that was the heavy dumping the past few days was new 40-45m shares hitting the market.

-the upside is not all holders will sell at these levels.

Volume Monday- 35.9m

Volume Tuesday- 31.19m

Volume Wednesday- 4.67m as of 11am

Clearly the big dumping is over... Now we have a lot of shorts out there to cover, otherwise most of the dilution is over.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 394

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
EyePoint Lawsuit Puts DURAVYU Claims Under a Microscope

Updated Category News Views 55

Nothing makes biotech investors reach for the aspirin faster than a lawsuit centered on whether a drug worked as advertised. EyePoint, Inc. is facing a proposed federal securities class action alleging that the company overstated the effectiveness of DURAVYU and, by extension, its clinical, regulatory, and commercial prospects. That is a serious allegation, but it remains...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 137

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 410

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 98

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading
Build-A-Bear Lawsuit Notice Carries a Date Problem

Updated Category News Views 49

Something is badly out of sequence in the Build-A-Bear shareholder alert, and that matters before anybody gets carried away by the legal boilerplate. The notice says investors who bought NYSE: BBW securities from March 28, 2026 through August 26, 2026 may be covered by a proposed federal securities class action. It also says the lead-plaintiff deadline is January 19,...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 191

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 618

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
DKSH's Vietnam Oncology Pact Carries Real Promise, Risk

Updated Category News Views 52

A cancer-market announcement ought to make investors pause before they reach for a spreadsheet. Specialised Therapeutics and DKSH have signed an exclusive partnership to bring oncology therapies into Vietnam, and the human case is painfully clear: the country recorded an estimated 180,000 new cancer cases and more than 120,000 deaths annually in the 2022 GLOBOCAN data....

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 445

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrating the Legacy of the Kashi Fair: A Cultural Journey

Updated Category News Views 387

The Kashi Fair: A Living Tribute to the Silk Road The Kashi Fair, also known as the Kashi-Central and South Asia Commodity Fair, has become an essential trade event, connecting cultures and economies while celebrating the essence of the historic Silk Road. For Pakistani businessman Muhammad Abbas, the Managing Director of Pakistan Northern Gems, this annual event in Kashi...

Continue Reading
Global Forum Focuses on Sustainable Future and Cooperation

Updated Category News Views 260

Global Leaders Gather to Discuss a Sustainable Future Under the theme "Collective Action for One Future", a significant forum took place in a vibrant city, bringing together over 130 leaders from various nations. This event marked the ninth edition of an esteemed international gathering focused on transformative issues affecting the worldwide landscape. For the first...

Continue Reading
Blue Onion Secures $10 Million to Enhance Financial Data Management

Updated Category News Views 294

Blue Onion Secures $10 Million Series A Funding In a significant advancement for financial data management, Blue Onion has successfully secured $10 million in a Series A funding round, led by Viola FinTech. This strategic investment aims to broaden Blue Onion's capabilities in delivering accurate and fully reconciled transaction-level data that CFOs can trust. With this...

Continue Reading
Lilly's Retatrutide Outshines Ozempic in Key Diabetes Trial

Updated Category News Views 120

Lilly's Breakthrough in Diabetes Treatment Eli Lilly's retatrutide is stirring up the diabetes treatment waters. The latest Phase 3 comparison to Ozempic's top dose reveals some surprising results. I'm not one to toss out kudos lightly, but this could be a genuine game-changer if things hold steady. A1C Reductions: A Close Look at the Numbers We’re staring down the...

Continue Reading
Investing in Houlihan Lokey: A Decade of Growth Insights

Updated Category News Views 176

Understanding the Investment Journey with Houlihan Lokey Houlihan Lokey (NYSE: HLI) has demonstrated remarkable performance over the past decade. This investment bank has outshined market averages, yielding an impressive annualized return of 22.61%. As of now, Houlihan Lokey boasts a significant market capitalization of $12.57 billion, showcasing its robust standing in...

Continue Reading